Covid-19 overlapping with systemic sclerosis

Mariano, Rachel Zerbini; Rio, Ana Paula Toledo Del; Reis, Fabiano

doi:10.1590/0037-8682-0450-2020

Cited by 11 publications

(7 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous COVID-19 cohort studies have been reported. In addition to the common clinical feature, multiple similar symptoms between COVID-19 and autoimmune diseases were found, including vascular inflammation, endothelial dysfunction and lung manifestations and occurrence of autoantibodies [ [1] , [2] , [3] ]. This paper provide an overview on the autoantibodies in COVID-19 patients.…”

mentioning

confidence: 99%

Autoantibodies in COVID-19: frequency and function

Gao

Zhang

Liu

et al. 2021

Autoimmunity Reviews

View full text Add to dashboard Cite

mentioning

confidence: 99%

Autoantibodies in COVID-19: frequency and function

Gao

Zhang

Liu

et al. 2021

Autoimmunity Reviews

View full text Add to dashboard Cite

“…Data about the association between COVID-19 and SLE [45][46][47] or SSc [13,48,49] are scarce. However, there have been reports in the literature of COVID-19 shortly preceding a de novo diagnosis of SLE, presenting concomitantly, mimicking or worsening SLE manifestations, raising the possibility of SARS-CoV-2 being an autoimmunity trigger [50][51][52][53][54][55].…”

Section: Discussionmentioning

confidence: 99%

The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus

Krawczyk

Mazur

Kargol

et al. 2021

Dermato

View full text Add to dashboard Cite

About 20% of patients with systemic sclerosis have symptoms of another connective tissue disease (CTD). Interstitial lung disease (ILD) is one of the most common organ manifestations in systemic sclerosis (SSc) as well as viral illnesses, such as COVID-19, and can lead not only to diffuse alveolar damage, but also trigger an exacerbation of fibrosis among patients with preexisting ILD. It is also associated with substantial morbidity and mortality. According to the World Scleroderma Foundation, SSc-ILD can mask or mimic early COVID-19 lesions and there are no available computed tomography guidelines on how to discern those two conditions. We present a case of systemic sclerosis exacerbation after COVID-19 in a patient with SSc-Lupus Overlap Syndrome.

show abstract

“…In another study, 42% of patients demonstrated residual lung changes at the 3-month follow-up between the first and second CT scans [ 53 ]. Imaging findings often observed in systemic sclerosis are either non-specific interstitial pneumonia (NSIP) or usual interstitial pneumonia (UIP), which manifest as ground-glass opacities, and reticulation respectively [ 54 ]. These patterns are also seen in patients with COVID-19 pneumonia.…”

Section: Long Covid and Rheumatologymentioning

confidence: 99%